Tau pathology mediated the plasma biomarkers and cognitive function in patients with mild cognitive impairment
【Highlights】:
?Plasma markers (GFAP and NfL) and regional SUVRs of 18F-AV-1451 PET could distinguish patients with MCI from CN in two cohorts.
?Increased tau deposition in the amygdala and l...